abstract |
A stable pharmaceutical preparation containing anhuman growth hormone having a molecular weight of aboutn20,000, or a derivative thereof, can be formulated bynadding a water soluble heterocyclic compound, such asncreatinine, a salt of acetyltryptophane and nicotinamide,nto prevent the insolubilization of the human growth hormonenor the derivative thereof in an aqueous solution. |